Dr. Reddy's gets FDA nod for Xeglyze

Press enter to search
Close search
Open Menu

Dr. Reddy's gets FDA nod for Xeglyze

By Sandra Levy - 07/27/2020

Patients 6 months of age and older with head lice infestation will soon have a new topical treatment.

The Food and Drug Administration has cleared Dr. Reddy’s Xeglyze (abametapir) lotion, 0.74%

The company is working to commercialize this product through partners. 

Related Topics